Philip R. Schauer

Dr. Philip Schauer is the United Companies Life Insurance Co./Mary Kay and Terrell Brown endowed Professor of Metabolic Surgery at Pennington Biomedical Research Center of Louisiana State University in Baton Rouge, Louisiana. He is Director of the Metamor Metabolic Institute at Pennington Biomedical. He is formerly Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. He is past president of the American Society for Metabolic & Bariatric Surgery (ASMBS). He is former Chair and founder of Obesity Week (2012-present) and Co-Chair of the Diabetes Surgery Summit (2007, 2015, 2019). He is a graduate of Baylor College of Medicine in 1986. He completed surgical residency training at the University of Texas in San Antonio in 1993. He then completed one of the first fellowships in advanced laparoscopy at Duke University in 1995. He started his academic career at the University of Pittsburgh in 1995 and rose to the rank of Associate Professor of Surgery with tenure by 2004 when he was recruited to the Cleveland Clinic as Professor of Surgery and Director of Metabolic Surgery. Dr. Schauer's clinical interests include obesity, diabetes and metabolic surgery. He has performed more than 8000 operations for severe obesity and diabetes. His research interests include the pathophysiology of obesity and type 2 diabetes, and outcomes of metabolic surgery. He has authored more than 400 scientific papers, 60 textbook chapters, and 3 textbooks related to obesity, bariatric/metabolic surgery and gastrointestinal surgery. He has published his work in high impact journals such as New England Journal Medicine, JAMA, Lancet and others with more than 42,000 citations and a H-index of 93, highest amongst peers. He is principal investigator of the STAMPEDE trail comparing medical and surgical treatment of diabetes published in New England Journal of Medicine (2012, 2014, 2017) with more than 6000 citations and numerous awards from American Heart Association, American College of Cardiology, NIH and Wall Street Journal. He has been principal investigator on 3 NIH funded studies evaluating surgical treatment of diabetes and obesity. He is past chairman of the Bariatric Surgery Section of The Obesity Society (TOS). He has been a member of the editorial board of the International Journal of Obesity, Surgery for Obesity and Related Diseases and Obesity Surgery as well as 3 other scientific journals. He has been an invited speaker for more than 200 international lectures on the subject of metabolic surgery. He is founder of the Minimally Invasive Surgery Symposium (MISS) now in its 21th year. He has trained more than 200 postgraduate surgeons and 100 fellows in advanced laparoscopic and bariatric surgery (3 Presidents of ASMBS). He holds 4 patents for medical devices. He is the recipient of the Cleveland Clinic 2015 Sones Award – highest honor for scientific innovation at the Cleveland Clinic. He is the recipient of the SAGES Pioneer in Surgical Endoscopy Award 2018.